Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
Status:
Terminated
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who
have leptomeningeal metastases from a solid tumor or lymphoma.